Table of Contents
ISRN Obstetrics and Gynecology
Volume 2011, Article ID 524365, 13 pages
http://dx.doi.org/10.5402/2011/524365
Research Article

Feasibility of Repurposing the Polyanionic Microbicide, PPCM, for Prophylaxis against HIV Transmission during ART

1Department of Obstetrics and Gynecology, Rush University Medical Center, 1653 W. Congress Parkway, Chicago, IL 60612, USA
2AndroJek, Inc., 2145 W. Davie boulevard, Suite 103, Ft. Lauderdale, FL 33312, USA
3Department of Immunology and Microbiology, Rush University Medical Center, 1653 W. Congress Parkway, Chicago, IL 60612, USA

Received 29 September 2010; Accepted 19 October 2010

Academic Editors: M. A. Dhont, I. J. Kadoch, and T. Tanbo

Copyright © 2011 Robert A. Anderson et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. UNAIDS, “AIDS epidemic update,” Tech. Rep. UNAIDS/09.36E/JC1700E, UNAIDS/WHO, Geneva, Switzerland, December 2009. View at Google Scholar
  2. A. D. Lyerly and J. Anderson, “Human immunodeficiency virus and assisted reproduction: reconsidering evidence, reframing ethics,” Fertility and Sterility, vol. 75, no. 5, pp. 843–858, 2001. View at Publisher · View at Google Scholar
  3. “Support for sexual and reproductive health in people living with HIV/AIDS,” in Clinical Protocol for the WHO European Region. HIV/AIDS Treatment and Care Clinical Protocols for the WHO European Region, I. Eramova, S. Matic, and M. Munz, Eds., vol. 9, World Health Organization, Copenhagen, Denmark, 2006.
  4. C. Gilling-Smith, J. D. M. Nicopoullos, A. E. Semprini, and L. C. G. Frodsham, “HIV and reproductive care—a review of current practice,” An International Journal of Obstetrics and Gynaecology, vol. 113, no. 8, pp. 869–878, 2006. View at Publisher · View at Google Scholar · View at PubMed
  5. J. E. Peña, J. Klein, M. H. Thornton II, and M. V. Sauer II, “Providing assisted reproductive care to male haemophiliacs infected with human immunodeficiency virus: preliminary experience,” Haemophilia, vol. 9, no. 3, pp. 309–316, 2003. View at Google Scholar
  6. J. Stekler, B. J. Sycks, S. Holte et al., “HIV dynamics in seminal plasma during primary HIV infection,” AIDS Research and Human Retroviruses, vol. 24, no. 10, pp. 1269–1274, 2008. View at Publisher · View at Google Scholar · View at PubMed
  7. P. M. Sheth, C. Kovacs, K. S. Kemal et al., “Persistent HIV RNA shedding in semen despite effective antiretroviral therapy,” AIDS, vol. 23, no. 15, pp. 2050–2054, 2009. View at Publisher · View at Google Scholar · View at PubMed
  8. Y. Englert, B. Lesage, J.-P. Van Vooren et al., “Medically assisted reproduction in the presence of chronic viral diseases,” Human Reproduction Update, vol. 10, no. 2, pp. 149–162, 2004. View at Publisher · View at Google Scholar · View at PubMed
  9. J. Y. Phelps, “Restricting access of human immunodeficiency virus (HIV)-seropositive patients to infertility services: a legal analysis of the rights of reproductive endocrinologists and of HIV-seropositive patients,” Fertility and Sterility, vol. 88, no. 6, pp. 1483–1490, 2007. View at Publisher · View at Google Scholar · View at PubMed
  10. D. J. Anderson, H. Wolff, J. Pudney, Z. Wenhao, A. Martinez, and K. Mayer, “Presence of HIV in semen,” in Heterosexual Transmission of AIDS: Proceedings of the Second Contraceptive Research and Development (CONRAD) Program International Workshop, N. J. Alexander, H. L. Gabelnick, and J. M. Spieler, Eds., pp. 167–180, John Wiley & Sons, New York, NY, USA, 1990. View at Google Scholar
  11. L. Bujan, L. Hollander, M. Coudert et al., “Safety and efficacy of sperm washing in HIV-1-serodiscordant couples where the male is infected: results from the European CREAThE network,” AIDS, vol. 21, no. 14, pp. 1909–1914, 2007. View at Publisher · View at Google Scholar · View at PubMed
  12. V. Savasi, E. Ferrazzi, C. Lanzani, M. Oneta, B. Parrilla, and T. Persico, “Safety of sperm washing and ART outcome in 741 HIV-1-serodiscordant couples,” Human Reproduction, vol. 22, no. 3, pp. 772–777, 2007. View at Publisher · View at Google Scholar · View at PubMed
  13. California Health and Safety Code, Section 1644.5, SB 443: 28 August 2007.
  14. N. Barnhart, M. Shannon, S. Weber, and D. Cohan, “Assisted reproduction for couples affected by human immunodeficiency virus in California,” Fertility and Sterility, vol. 91, no. 4, pp. 1540–1543, 2009. View at Publisher · View at Google Scholar · View at PubMed
  15. S. Marina, F. Marina, R. Alcolea et al., “Human immunodeficiency virus type 1-serodiscordant couples can bear healthy children after undergoing intrauterine insemination,” Fertility and Sterility, vol. 70, no. 1, pp. 35–39, 1998. View at Publisher · View at Google Scholar
  16. J. D. M. Nicopoullos, P. A. Almeida, J. W. A. Ramsay, and C. Gilling-Smith, “The effect of human immunodeficiency virus on sperm parameters and the outcome of intrauterine insemination following sperm washing,” Human Reproduction, vol. 19, no. 10, pp. 2289–2297, 2004. View at Publisher · View at Google Scholar · View at PubMed
  17. E. Dussaix, D. Guetard, C. Dauguet et al., “Spermatozoa as potential carriers of HIV,” Research in Virology, vol. 144, no. 6, pp. 487–495, 1993. View at Google Scholar
  18. L. U. Kim, M. R. Johnson, S. Barton et al., “Evaluation of sperm washing as a potential method of reducing HIV transmission in HIV-discordant couples wishing to have children,” AIDS, vol. 13, no. 6, pp. 645–651, 1999. View at Publisher · View at Google Scholar
  19. B. Baccetti, A. Benedetto, A. G. Burrini et al., “HIV-particles in spermatozoa of patients with AIDS and their transfer into the oocyte,” Journal of Cell Biology, vol. 127, no. 4, pp. 903–914, 1994. View at Publisher · View at Google Scholar
  20. A. Ceballos, F. R. Lenicov, J. Sabatté et al., “Spermatozoa capture HIV-1 through heparan sulfate and efficiently transmit the virus to dendritic cells,” Journal of Experimental Medicine, vol. 206, no. 12, pp. 2717–2733, 2009. View at Publisher · View at Google Scholar · View at PubMed
  21. O. Bagasra, M. Freund, J. Weidmann, and G. Harley, “Interaction of human immunodeficiency virus with human sperm in vitro,” Journal of Acquired Immune Deficiency Syndromes, vol. 1, no. 5, pp. 431–435, 1988. View at Google Scholar
  22. L. Bujan, C. Gilling-Smith, L. Hollander, E. A. Semprini, and P. Vernazza, “Lack of clinical and scientific evidence to justify the systematic use of ICSI in HIV-serodiscordant couples wishing to conceive where the male partner is infected,” Fertility and Sterility, vol. 91, no. 3, pp. e1–e2, 2009. View at Publisher · View at Google Scholar · View at PubMed
  23. O. J. D'Cruz and F. M. Uckun, “Clinical development of microbicides for the prevention of HIV infection,” Current Pharmaceutical Design, vol. 10, no. 3, pp. 315–336, 2004. View at Publisher · View at Google Scholar
  24. C. K. Mauck, D. H. Weiner, S. A. Ballagh et al., “Single and multiple exposure tolerance study of polystyrene sulfonate gel: a phase I safety and colposcopy study,” Contraception, vol. 70, no. 1, pp. 77–83, 2004. View at Publisher · View at Google Scholar · View at PubMed
  25. C. Plescia, “Microbicide clinical trials,” in The Microbicide Quarterly, B. M. Finley and P. F. Harrison, Eds., vol. 24, Alliance for Microbicide Development, Silver Spring, Md, USA, June 2005. View at Google Scholar
  26. N. Joglekar, S. Joshi, M. Kakde et al., “Acceptability of PRO2000 vaginal gel among HIV un-infected women in Pune, India,” AIDS Care, vol. 19, no. 6, pp. 817–821, 2007. View at Publisher · View at Google Scholar · View at PubMed
  27. L. J. D. Zaneveld, R. A. Anderson, X.-H. Diao et al., “Use of mandelic acid condensation polymer (SAMMA), a new antimicrobial contraceptive agent, for vaginal prophylaxis,” Fertility and Sterility, vol. 78, no. 5, pp. 1107–1115, 2002. View at Publisher · View at Google Scholar
  28. B. C. Herold, I. Scordi-Bello, N. Cheshenko et al., “Mandelic acid condensation polymer: novel candidate microbicide for prevention of human immunodeficiency virus and herpes simplex virus entry,” Journal of Virology, vol. 76, no. 22, pp. 11236–11244, 2002. View at Publisher · View at Google Scholar
  29. N. Cheshenko, M. J. Keller, V. MasCasullo et al., “Candidate topical microbicides bind herpes simplex virus glycoprotein B and prevent viral entry and cell-to-cell spread,” Antimicrobial Agents and Chemotherapy, vol. 48, no. 6, pp. 2025–2036, 2004. View at Publisher · View at Google Scholar · View at PubMed
  30. R. A. Anderson, K. A. Feathergill, D. P. Waller, and L. J. D. Zaneveld, “SAMMA induces premature human acrosomal loss by Ca2+ signaling dysregulation,” Journal of Andrology, vol. 27, no. 4, pp. 568–577, 2006. View at Publisher · View at Google Scholar · View at PubMed
  31. T. L. Chang, N. Teleshova, A. Rapista et al., “SAMMA, a mandelic acid condensation polymer, inhibits dendritic cell-mediated HIV transmission,” FEBS Letters, vol. 581, no. 24, pp. 4596–4602, 2007. View at Publisher · View at Google Scholar · View at PubMed
  32. R. A. Anderson Jr., K. A. Feathergill, C. J. Chany II, S. Jain, and A. Krunic, “Nitric oxide - Dependent human acrosomal loss induced by PPCM (SAMMA) and nitric oxide donors occurs by independent pathways: basis for synthesis of an improved contraceptive microbicide,” Journal of Andrology, vol. 30, no. 2, pp. 168–182, 2009. View at Publisher · View at Google Scholar · View at PubMed
  33. P. M. M. Mesquita, S. S. Wilson, P. Manlow et al., “Candidate microbicide PPCM blocks human immunodeficiency virus type 1 infection in cell and tissue cultures and prevents genital herpes in a murine model,” Journal of Virology, vol. 82, no. 13, pp. 6576–6584, 2008. View at Publisher · View at Google Scholar · View at PubMed
  34. G. F. Doncel, “Exploiting common targets in human fertilization and HIV infection: development of novel contraceptive microbicides,” Human Reproduction Update, vol. 12, no. 2, pp. 103–117, 2006. View at Publisher · View at Google Scholar · View at PubMed
  35. R. E. Homm, R. G. Foldesy, and D. W. Hahn, “ORF 13904, a new long-acting vaginal contraceptive,” Contraception, vol. 32, no. 3, pp. 267–274, 1985. View at Google Scholar
  36. R. A. Anderson, K. Feathergill, X. Diao et al., “Evaluation of poly(styrene-4-sulfonate) as a preventive agent for conception and sexually transmitted diseases,” Journal of Andrology, vol. 21, no. 6, pp. 862–875, 2000. View at Google Scholar
  37. C. K. Mauck, R. G. Freziers, T. L. Walsh, K. Peacock, J. L. Schwartz, and M. M. Callahan, “Noncomparative contraceptive efficacy of cellulose sulfate gel,” Obstetrics and Gynecology, vol. 111, no. 3, pp. 739–746, 2008. View at Publisher · View at Google Scholar · View at PubMed
  38. J. Biggers, W. Whitten, D. Whittingham, and W. Freeman, “The culture of mouse embryos in vitro,” in Methods in Mammalian Embryology, J. Daniel, Ed., pp. 86–116, W.H. Freeman, San Francisco, Calif, USA, 1971. View at Google Scholar
  39. R. A. Anderson Jr., K. A. Feathergill, C. J. De Jonge, S. R. Mack, and L. J. D. Zaneveld, “Facilitative effect of pulsed addition of dibutyryl cAMP on the acrosome reaction of noncapacitated human spermatozoa,” Journal of Andrology, vol. 13, no. 5, pp. 398–408, 1992. View at Google Scholar
  40. R. A. Anderson, K. A. Feathergill, R. C. Drisdel, R. G. Rawlins, S. R. Mack, and L. J. D. Zaneveld, “Atrial natriuretic peptide (ANP) as a stimulus of the human acrosome reaction and a component of ovarian follicular fluid: correlation of follicular ANP content with in vitro fertilization outcome,” Journal of Andrology, vol. 15, no. 1, pp. 61–70, 1994. View at Google Scholar
  41. D. B. Brown, E. J. Hayes, T. Uchida, and M. Nagamani, “Some cases of human male infertility are explained by abnormal in vitro human sperm activation,” Fertility and Sterility, vol. 64, no. 3, pp. 612–622, 1995. View at Google Scholar
  42. D. P. Evenson, L. K. Jost, D. Marshall et al., “Utility of the sperm chromatin structure assay as a diagnostic and prognostic tool in the human fertility clinic,” Human Reproduction, vol. 14, no. 4, pp. 1039–1049, 1999. View at Google Scholar
  43. R. Sokal and F. J. Rohlf, “Assumptions of analysis of variance,” in Biometry, pp. 400–453, W.H. Freeman, San Francisco, Calif, USA, 1981. View at Google Scholar
  44. C. M. Woolf, Principles of Biometry, D Van Nostrand, Princeton, NJ, USA, 1968.
  45. B. C. Herold, N. Bourne, D. Marcellino et al., “Poly(sodium 4-styrene sulfonate): an effective candidate topical antimicrobial for the prevention of sexually transmitted diseases,” Journal of Infectious Diseases, vol. 181, no. 2, pp. 770–773, 2000. View at Publisher · View at Google Scholar · View at PubMed
  46. R. A. Anderson, K. A. Feathergill, X.-H. Diao et al., “Preclinical evaluation of sodium cellulose sulfate (UshercellTM) as a contraceptive antimicrobial agent,” Journal of Andrology, vol. 23, no. 3, pp. 426–438, 2002. View at Google Scholar
  47. L. J. D. Zaneveld, D. P. Waller, R. A. Anderson et al., “Efficacy and safety of a new vaginal contraceptive antimicrobial formulation containing high molecular weight poly(sodium 4-styrenesulfonate),” Biology of Reproduction, vol. 66, no. 4, pp. 886–894, 2002. View at Google Scholar
  48. J. A. Simoes, D. M. Citron, A. Aroutcheva et al., “Two novel vaginal microbicides (polystyrene sulfonate and cellulose sulfate) inhibit Gardnerella vaginalis and anaerobes commonly associated with bacterial vaginosis,” Antimicrobial Agents and Chemotherapy, vol. 46, no. 8, pp. 2692–2695, 2002. View at Publisher · View at Google Scholar
  49. M. J. Keller, M. E. Klotman, and B. C. Herold, “Rigorous pre-clinical evaluation of topical microbicides to prevent transmission of human immunodeficiency virus,” Journal of Antimicrobial Chemotherapy, vol. 51, no. 5, pp. 1099–1102, 2003. View at Publisher · View at Google Scholar · View at PubMed
  50. M. J. Keller, B. Zerhouni-Layachi, N. Cheshenko et al., “PRO 2000 gel inhibits HIV and herpes simplex virus infection following vaginal application: a double-blind placebo-controlled trial,” Journal of Infectious Diseases, vol. 193, no. 1, pp. 27–35, 2006. View at Publisher · View at Google Scholar · View at PubMed
  51. M. Ward, B. Yu, V. Wyatt et al., “Anti-HIV-1 activity of poly(mandelic acid) derivatives,” Biomacromolecules, vol. 8, no. 11, pp. 3308–3316, 2007. View at Publisher · View at Google Scholar · View at PubMed
  52. A. R. Neurath, N. Strick, and Y.-Y. Li, “Anti-HIV-1 activity of anionic polymers: a comparative study of candidate microbicides,” BMC Infectious Diseases, vol. 2, article 27, 11 pages, 2002. View at Publisher · View at Google Scholar
  53. M. Bungum, P. Humaidan, A. Axmon et al., “Sperm DNA integrity assessment in prediction of assisted reproduction technology outcome,” Human Reproduction, vol. 22, no. 1, pp. 174–179, 2007. View at Publisher · View at Google Scholar · View at PubMed
  54. S. A. Krawetz, “Defining sites susceptible to DNA damage within the sperm nucleus: the nuclear matrix connection,” in Proceedings Sperm DNA Damage: From Research to Clinic, vol. 21, Informa Healthcare, Rome, Italy, March 2009.
  55. H. E. Gendelman, L. M. Baca, J. Turpin et al., “Regulation of HIV replication in infected monocytes by IFN-α: mechanisms for viral restriction,” Journal of Immunology, vol. 145, no. 8, pp. 2669–2676, 1990. View at Google Scholar
  56. M. A. Winters, M. Holodniy, D. A. Katzenstein, and T. C. Merigan, “Quantitative RNA and DNA gene amplification can rapidly monitor HIV infection and antiviral activity in cell cultures,” Genome Research, vol. 1, no. 4, pp. 257–262, 1992. View at Google Scholar
  57. E. Lirri, “Doctors speak out on failed AIDS trials,” Monitor Publications, Ltd., August 2007, http://allafrica.com/stories/200708180112.html.
  58. S. Skoler-Karpoff, G. Ramjee, K. Ahmed et al., “Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial,” The Lancet, vol. 372, no. 9654, pp. 1977–1987, 2008. View at Publisher · View at Google Scholar
  59. L. Van Damme, R. Govinden, F. M. Mirembe et al., “Lack of effectiveness of cellulose sulfate gel for the prevention of vaginal HIV transmission,” The New England Journal of Medicine, vol. 359, no. 5, pp. 463–472, 2008. View at Publisher · View at Google Scholar · View at PubMed
  60. S. Lister, “AIDS research suffers setback as big trial of 'infection blocking' gel fails,” Times Online, Times Newspapers, Ltd., December 2009, http://www.timesonline.co.uk/tol/news/science/medicine/article6955258.ece.
  61. A. N. Turner, A. E. De Kock, A. Meehan-Ritter et al., “Many vaginal microbicide trial participants acknowledged they had misreported sensitive sexual behavior in face-to-face interviews,” Journal of Clinical Epidemiology, vol. 62, no. 7, pp. 759–765, 2008. View at Publisher · View at Google Scholar · View at PubMed
  62. T. Swan and D. Raymond, Hepatitis C Virus (HCV) and HIV/HCV Coinfection: A Critical Review of Research and Treatment, Treatment Action Group, New York, NY, USA, 2004.
  63. C. Ying, J. F. Van Pelt, A. Van Lommel et al., “Sulphated and sulphonated polymers inhibit the initial interaction of hepatitis B virus with hepatocytes,” Antiviral Chemistry and Chemotherapy, vol. 13, no. 3, pp. 157–164, 2002. View at Google Scholar
  64. A. Zahn and J.-P. Allain, “Hepatitis C virus and hepatitis B virus bind to heparin: purification of largely IgG-free virions from infected plasma by heparin chromatography,” Journal of General Virology, vol. 86, no. 3, pp. 677–685, 2005. View at Publisher · View at Google Scholar · View at PubMed